BQ-123
BQ-123 is a potent and selective endothelin A (ETA) receptor antagonist with an IC50 of 7.3 nM. This compound is a valuable research tool for investigating the role of ET-1 signaling in cardiovascular diseases, pulmonary hypertension, and cancer, as demonstrated in various in vitro and in vivo studies. It has been evaluated in Phase 2 clinical trials.
Product Specifications
Product Name Alternative
Cells, BQ 123, BQ123, BQ-123, blood, artery, EndothelinReceptor, Endothelin Receptor, Endothelin A receptor, Inhibitor, inhibit, muscle, smooth, pulmonary, pressure
Field of Research
Pharmacology & Drug Discovery
Purity
≥95% (May vary between batches)
Solubility
Ethanol:12 mg/mL (19.65 mM) ; DMSO:93 mg/mL (152.28 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.19 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Molecular Weight
610.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS643965-100ug 100 µg
Transmembrane protein 88B (TMEM88B) (NM_001146685) Human Over-expression Lysate
Sign In for Pricing
View Details C2548-95W-ML405 100 µL
CD200 (CD200 Antigen, MOX1, MOX2, MRC, My033, OX2, OX-2 Membrane Glycoprotein, OX2G) (MaxLight 405) discontinued
Sign In for Pricing
View Details 